Atazanavir use and carotid intima media thickness progression in HIV: potential influence of bilirubin

AIDS. 2016 Feb 20;30(4):672-4. doi: 10.1097/QAD.0000000000000970.

Authors

Dominic Chow¹, Lindsay Kohorn, Scott Souza, Lishomwa Ndhlovu, Akika Ando, Kalpana J Kallianpur, Mary Margaret Byron, Yvonne Baumer, Sheila Keating, Cecilia Shikuma

Affiliation

¹ aHawaii Center for AIDS, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii, USA bBlood Systems Research Institute, Core Immunology Laboratory, Blood Systems Research Institute, San Francisco, CA, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Anti-HIV Agents / therapeutic use*
Atazanavir Sulfate / therapeutic use*
Atherosclerosis / pathology*
Bilirubin / blood*
Carotid Intima-Media Thickness*
Female
HIV Infections / complications*
HIV Infections / drug therapy*
Humans
Male
Retrospective Studies

Substances

Anti-HIV Agents
Atazanavir Sulfate
Bilirubin

Grants and funding